British Patient Capital
Government fundLondon · Series A–Growth
What they invest in
from 10 of 11 portfolio companiesBiotech ×5Healthtech ×5AI & Machine Learning ×4Deep Tech ×4Digital Health ×4Medical Devices ×3SaaS ×3Cleantech ×2
HQs:United Kingdom×6China×1United States×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12022 · 12017 · 15 dated
Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.
CleantechDeep TechHardwareSemiconductorsCambridge, GB
Co-investorsIn-Q-TelProsperity7 VenturesARMCambridge Innovation CapitalCatalystNorth East Development Capital Fund+4 more
TOM VIP邮箱 provides a paid email service for individuals and businesses, offering SSL-encrypted email, a dedicated VIP channel, and mobile email management integrated with WeChat.
Enterprise SoftwareSaaS
Co-investorsCathay Capital
Accurx builds a communication platform that connects patients with healthcare professionals, supporting tasks like appointment booking, patient contact, referrals, video consultations, and health surveys.
Digital HealthHealthtechSaaSLondon, GB
Jacob Haddad(CEO)inLaurence Bargery(Founding CTO)in
Co-investorsEntrepreneur FirstMoonfire VenturesTranspose Platform ManagementAtomicoLakestar
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.
AI & Machine LearningBiotechDeep TechHealthtech
Jane Osbourn(Chief Executive Officer)
Co-investorsSV Health InvestorsDCVC BioRA CapitalDementia Discovery FundLightstone VenturesOno Venture Investment, Inc.+2 more
Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.
CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB
Fabio Necco(CEO)in
Co-investorsCambridge Innovation CapitalEMV CapitalIQ CapitalMartlet Capital
CloudNC develops CAM Assist, software for machine shops that automates programming, quoting, and tool selection to reduce manual work and increase productivity.
Advanced ManufacturingAI & Machine LearningEnterprise SoftwareSaaSLondon, GB
Theo Saville(Founder)inChris Emery(CTO)in
Co-investorsAdelineBackedBootstrap EuropeEntrepreneur FirstEpisode1GRIDS Capital+7 more
Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.
BiotechDigital HealthHealthtechMedical DevicesOxford, GB
Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in
Co-investorsAndera PartnersCanaan PartnersOxford Science EnterprisesPfizer Venture InvestmentsEarlybird Venture CapitalPfizer Ventures
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsJJDCPfizer Ventures
Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOxford, GB
Rajarshi Banerjee(CEO)in
Co-investorsBlue Venture FundsHealthQuest Capital
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.
BiotechDigital HealthHealthtechMedical Devices
Moin Saleem(Co-founder & Chief Scientific Advisor)in
Co-investorsSofinnova PartnersForbionGilde Healthcare
Portfolio news
latest coverage across their companies163 · khqa.com · Aug 13, 2026
Oxx · financialit.net · Aug 13, 2026
Alchemab Therapeutics · healthcaretoday.com · Jul 22, 2026
Purespring · purespringtx.com · Oct 4, 2025
Accurx · tech.eu · Jul 14, 2025
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2023
Director · British · since 2025
Director · British · since 2025
Director · British · since 2022
Bbb Investment Holdings Limited — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- What stage does British Patient Capital invest at?
- British Patient Capital invests at the Series A, Series B, Series C, Growth stages.
- What sectors does British Patient Capital focus on?
- British Patient Capital focuses on Sector Agnostic.
- Where is British Patient Capital located?
- British Patient Capital is headquartered in London, GB.
Similar investors
Method Capital is a Chicago-based venture firm that partners with entrepreneurs to provide growth funding, focused primarily on Midwest-based technology companies. It aims to build a world-class investment firm known for strong partnerships with portfolio management and rigorous stewardship of investor capital.
Blue 9 Capital is a New York City-based family office that invests in private companies via direct equity and fund investments across a range of sectors.
Ion Pacific is an investment firm focused on the venture capital ecosystem, connecting LP investors to venture opportunities and providing liquidity solutions and creative capital to venture stakeholders.
Bridge Latam is a venture investment firm established in 2014 with roots in Mexico City, backing technology founders from seed through pre-IPO rounds in both local and global markets. Its team draws on over a decade of investing experience and connects portfolio companies with capital sources and partners; portfolio companies include Kavak.
NZ Growth Capital Partners is a New Zealand government-backed investor that supports early-stage and high-growth Kiwi technology startups, partnering with other investors and venture capital funds.